subject: Cephalon, Inc. - Swot Analysis - Aarkstore Enterprise. [print this page] Cephalon, IncCephalon, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Cephalon is a global biopharmaceutical company engaged in developing and marketing drugs in four therapeutic areas: central nervous system (CNS) disorders, pain, cancer and addiction. The company is headquartered in Frazer, Pennsylvania and employs about 2,800 people. The company recorded revenues of $1,772.3 million during the financial year (FY) ended December 2007, an increase of 0.5% over 2006. The operating loss of the company was $99.1 million during FY2006, as compared to an operating profit of $294.1 million in 2006. The net loss was $191.7 million in FY 2007, as compared to a net profit of $144.8 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors business structure, strategy and prospects
- Obtain the most up to date company information available
Table of Contents :
This product typically includes the following sections:
